Investors keep $UNVC on your radar.
Just to re-cap. Today, we wait for news regarding UNVC and the partnership with AGRiMED. Since AGRiMED once again mentioned the transdermal patch as a new product soon to be introduced in yesterday’s tweet, and since we were told AGRiMED prefers the UNVC patch, it seems logical AGRiMED is referring to the UNVC patch. If AGRiMED was not impressed with Dr. Dalton and the UNVC patch, why would AGRiMED appoint Dr. Dalton to their Board of Directors, and then promote him to Vice Chairman of the Board of Directors in rapid order right after AGRiMED announced their partnership? Did I mention that AGRiMED actually announced this partnership and not Univec? Did I mention that AGRiMED specifically mentioned the UNVC patch in this partnership announcement?
In addition, nearly everyone in management at AGRiMED has connections of some sort with the military and with the treatment of various problems associated with veteran healthcare. AGRiMED has posted their plan to treat PTSD, Opioid addiction, cancers, and numerous other maladies veterans as well as non-veterans are prone to suffer from. So, one thing I am looking for and frankly hoping for is a little talk very soon about a government contract or two. I suspect a contract will not happen right away, but some mention of this would be helpful in my opinion.
Now many on this board express the hope and strong desire for a reverse merger between AGRiMED and Univec as a low cost and expedited means of going public. There is no doubt such a move would catapult UNVC stock price. And, a big government contract would certainly make a reverse merger very attractive to AGRiMED, provided the UNVC patch is part of that equation.
This is just my two cents. However, there are many other possibilities, and no one really knows what AGRiMED intends to do.
Should the above scenario occur, I suspect many would need to raise their expectations of where this partnership might go, and how much early investors might prosper. Good times ahead here folks.
Just to re-cap. Today, we wait for news regarding UNVC and the partnership with AGRiMED. Since AGRiMED once again mentioned the transdermal patch as a new product soon to be introduced in yesterday’s tweet, and since we were told AGRiMED prefers the UNVC patch, it seems logical AGRiMED is referring to the UNVC patch. If AGRiMED was not impressed with Dr. Dalton and the UNVC patch, why would AGRiMED appoint Dr. Dalton to their Board of Directors, and then promote him to Vice Chairman of the Board of Directors in rapid order right after AGRiMED announced their partnership? Did I mention that AGRiMED actually announced this partnership and not Univec? Did I mention that AGRiMED specifically mentioned the UNVC patch in this partnership announcement?
In addition, nearly everyone in management at AGRiMED has connections of some sort with the military and with the treatment of various problems associated with veteran healthcare. AGRiMED has posted their plan to treat PTSD, Opioid addiction, cancers, and numerous other maladies veterans as well as non-veterans are prone to suffer from. So, one thing I am looking for and frankly hoping for is a little talk very soon about a government contract or two. I suspect a contract will not happen right away, but some mention of this would be helpful in my opinion.
Now many on this board express the hope and strong desire for a reverse merger between AGRiMED and Univec as a low cost and expedited means of going public. There is no doubt such a move would catapult UNVC stock price. And, a big government contract would certainly make a reverse merger very attractive to AGRiMED, provided the UNVC patch is part of that equation.
This is just my two cents. However, there are many other possibilities, and no one really knows what AGRiMED intends to do.
Should the above scenario occur, I suspect many would need to raise their expectations of where this partnership might go, and how much early investors might prosper. Good times ahead here folks.
